Debulking metastases of pancreatic neuroendocrine tumors (PNETs) may be effective at a threshold of greater than or equal to 70%, indicating that liver debulking criteria could possibly be extend to this threshold, according to a recent study.

Read More

Conferences

Patients with pancreatic cancer formally believed to not be eligible for surgery may in fact benefit from resection, according to findings from two recent studies.  

Read More

Galunisertib plus gemcitabine may improve overall survival and progression-free survival compared to gemcitabine alone in patients with pancreatic cancer, according to a study presented at the American Association for Cancer Research Annual Meeting (April 16-20, 2016; New Orleans, LA).

Read More

News

Debulking metastases of pancreatic neuroendocrine tumors (PNETs) may be effective at a threshold of greater than or equal to 70%, indicating that liver debulking criteria could possibly be extend to this threshold, according to a recent study.

Read More

The National Comprehensive Cancer Network (NCCN) has released their latest guidelines for the treatment of pancreatic adenocarcinoma, featuring a new therapy in the second-line setting.

Read More

Multiple preoperative indicators may be used as prognostic markers for patients with operable pancreatic ductal adenocarcinoma, according to a new study.

Read More

By Reuters Staff

NEW YORK (Reuters Health) – The pancreatic cancer resectability criteria advocated by the National Comprehensive Cancer Network (NCCN) may be more complicated than necessary, Japanese researchers say.

Read More

Research in Review

The addition of radiation therapy to chemotherapy improved overall survival (OS) in patients with unresected locally advanced pancreatic cancer, according to research presented at the 2017 ASCO Annual Meeting (June 2-6, 2017; Chicago, IL).

-----

Related Content

Read More

A new tyrosine kinase inhibitor (TKI) in combination with gemcitabine does not improve overall survival (OS) any more than gemcitabine alone for patients with advanced pancreatic cancer, according to a study published in The Lancet Oncology (published online March 2017; doi:10.1016/S1470-2045(17)30084-0).
-----
Related Content

Read More

Online materials about pancreatic cancer may lack accurate information about alternative therapy and be too complicated to benefit patients with the disease, claims a recent study.

Read More

Adding radiation to chemotherapy regimens may not improve overall survival compared with chemotherapy alone in patients with locally advanced pancreatic cancer, according to results from a clinical trial.

Read More

Subscribe to Pancreatic Cancer